Publication

Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunction

See how ALBI‑based PopPK modelling supports practical voriconazole dose reductions in liver dysfunction using Phoenix…

CertaraJuly 2, 2025

Publication

Bioequivalence study of two formulations of lurasidone film coated tablets in healthy subjects under fed conditions

Learn how fed‑condition crossover study confirms lurasidone bioequivalence and comparable safety using Phoenix WinNonlin.

CertaraJuly 1, 2025

Publication

Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study

Find out how PopPK modelling shows body weight is the key driver of MPA exposure…

CertaraJuly 1, 2025

Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…

CertaraJune 26, 2025

Publication

In Vivo PK-PD and Drug-Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia

Explore how dorzagliatin increases exposure and improves antitumor efficacy when combined with PI3Kα inhibitors, analysed…

CertaraJune 19, 2025

On-Demand Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

CertaraJune 18, 2025

On-Demand Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

CertaraJune 11, 2025

Publication

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…

CertaraJune 8, 2025

Publication

Population Pharmacokinetics of Tranexamic Acid in Chinese Population Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Discover how the First Chinese TXA PopPK model shows body weight drives TXA disposition and…

CertaraMay 26, 2025

On-Demand Webinar

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

CertaraMay 21, 2025

Clinical Pharmacology

Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunction

Bioequivalence study of two formulations of lurasidone film coated tablets in healthy subjects under fed conditions

Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study

How Model-informed drug development rescue projects from a risky situation

In Vivo PK-PD and Drug-Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Population Pharmacokinetics of Tranexamic Acid in Chinese Population Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

Newsletter sign up

Quick links

Solutions

Contact